vs

Side-by-side financial comparison of Energy Recovery, Inc. (ERII) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

Energy Recovery, Inc. is the larger business by last-quarter revenue ($66.9M vs $44.6M, roughly 1.5× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). Energy Recovery, Inc. runs the higher net margin — 40.2% vs -90.4%, a 130.7% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -0.3%). Energy Recovery, Inc. produced more free cash flow last quarter ($6.4M vs $-19.9M). Over the past eight quarters, Energy Recovery, Inc.'s revenue compounded faster (8.1% CAGR vs 7.3%).

Energy Recovery Inc. is an American manufacturer of energy recovery devices for water and CO2 refrigeration industries.

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

ERII vs PACB — Head-to-Head

Bigger by revenue
ERII
ERII
1.5× larger
ERII
$66.9M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+14.1% gap
PACB
13.8%
-0.3%
ERII
Higher net margin
ERII
ERII
130.7% more per $
ERII
40.2%
-90.4%
PACB
More free cash flow
ERII
ERII
$26.3M more FCF
ERII
$6.4M
$-19.9M
PACB
Faster 2-yr revenue CAGR
ERII
ERII
Annualised
ERII
8.1%
7.3%
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ERII
ERII
PACB
PACB
Revenue
$66.9M
$44.6M
Net Profit
$26.9M
$-40.4M
Gross Margin
67.2%
37.1%
Operating Margin
46.8%
-92.3%
Net Margin
40.2%
-90.4%
Revenue YoY
-0.3%
13.8%
Net Profit YoY
14.7%
-1802.7%
EPS (diluted)
$0.49
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ERII
ERII
PACB
PACB
Q4 25
$66.9M
$44.6M
Q3 25
$32.0M
$38.4M
Q2 25
$28.1M
$39.8M
Q1 25
$37.2M
Q4 24
$67.1M
$39.2M
Q3 24
$38.6M
$40.0M
Q2 24
$27.2M
$36.0M
Q1 24
$12.1M
$38.8M
Net Profit
ERII
ERII
PACB
PACB
Q4 25
$26.9M
$-40.4M
Q3 25
$3.9M
$-38.0M
Q2 25
$2.1M
$-41.9M
Q1 25
$-426.1M
Q4 24
$23.5M
$2.4M
Q3 24
$8.5M
$-60.7M
Q2 24
$-642.0K
$-173.3M
Q1 24
$-8.3M
$-78.2M
Gross Margin
ERII
ERII
PACB
PACB
Q4 25
67.2%
37.1%
Q3 25
64.2%
41.4%
Q2 25
64.0%
36.9%
Q1 25
-3.7%
Q4 24
70.2%
25.6%
Q3 24
65.1%
25.0%
Q2 24
64.6%
16.5%
Q1 24
59.0%
29.1%
Operating Margin
ERII
ERII
PACB
PACB
Q4 25
46.8%
-92.3%
Q3 25
11.4%
-101.1%
Q2 25
5.3%
-112.8%
Q1 25
-1154.5%
Q4 24
38.2%
-390.1%
Q3 24
18.3%
-160.3%
Q2 24
-7.4%
-488.3%
Q1 24
-90.4%
-209.6%
Net Margin
ERII
ERII
PACB
PACB
Q4 25
40.2%
-90.4%
Q3 25
12.1%
-98.9%
Q2 25
7.3%
-105.4%
Q1 25
-1146.8%
Q4 24
35.0%
6.0%
Q3 24
22.0%
-151.9%
Q2 24
-2.4%
-481.3%
Q1 24
-68.3%
-201.4%
EPS (diluted)
ERII
ERII
PACB
PACB
Q4 25
$0.49
$-0.11
Q3 25
$0.07
$-0.13
Q2 25
$0.04
$-0.14
Q1 25
$-1.44
Q4 24
$0.40
$-0.44
Q3 24
$0.15
$-0.22
Q2 24
$-0.01
$-0.64
Q1 24
$-0.14
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ERII
ERII
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$75.2M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.2M
$5.3M
Total Assets
$231.5M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ERII
ERII
PACB
PACB
Q4 25
$75.2M
$279.5M
Q3 25
$70.4M
$298.7M
Q2 25
$79.5M
$314.7M
Q1 25
$343.1M
Q4 24
$78.0M
$389.9M
Q3 24
$118.6M
$471.1M
Q2 24
$101.0M
$509.8M
Q1 24
$117.4M
$561.9M
Stockholders' Equity
ERII
ERII
PACB
PACB
Q4 25
$206.2M
$5.3M
Q3 25
$180.8M
$36.1M
Q2 25
$185.2M
$61.5M
Q1 25
$91.6M
Q4 24
$210.0M
$506.6M
Q3 24
$233.9M
$453.1M
Q2 24
$218.5M
$492.7M
Q1 24
$216.0M
$649.0M
Total Assets
ERII
ERII
PACB
PACB
Q4 25
$231.5M
$784.1M
Q3 25
$209.6M
$803.2M
Q2 25
$212.3M
$825.5M
Q1 25
$860.8M
Q4 24
$242.8M
$1.3B
Q3 24
$262.7M
$1.5B
Q2 24
$249.0M
$1.5B
Q1 24
$244.3M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ERII
ERII
PACB
PACB
Operating Cash FlowLast quarter
$7.1M
$-19.1M
Free Cash FlowOCF − Capex
$6.4M
$-19.9M
FCF MarginFCF / Revenue
9.6%
-44.6%
Capex IntensityCapex / Revenue
1.0%
1.9%
Cash ConversionOCF / Net Profit
0.26×
TTM Free Cash FlowTrailing 4 quarters
$15.8M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ERII
ERII
PACB
PACB
Q4 25
$7.1M
$-19.1M
Q3 25
$-3.1M
$-18.7M
Q2 25
$4.1M
$-29.4M
Q1 25
$-44.1M
Q4 24
$9.0M
$-30.6M
Q3 24
$-3.0M
$-45.5M
Q2 24
$8.1M
$-54.3M
Q1 24
$6.5M
$-75.7M
Free Cash Flow
ERII
ERII
PACB
PACB
Q4 25
$6.4M
$-19.9M
Q3 25
$-3.5M
$-18.8M
Q2 25
$4.0M
$-29.9M
Q1 25
$-45.4M
Q4 24
$8.9M
$-32.3M
Q3 24
$-3.2M
$-46.3M
Q2 24
$7.9M
$-55.7M
Q1 24
$5.7M
$-79.6M
FCF Margin
ERII
ERII
PACB
PACB
Q4 25
9.6%
-44.6%
Q3 25
-10.9%
-48.9%
Q2 25
14.3%
-75.3%
Q1 25
-122.3%
Q4 24
13.2%
-82.3%
Q3 24
-8.2%
-115.7%
Q2 24
28.9%
-154.8%
Q1 24
46.9%
-205.0%
Capex Intensity
ERII
ERII
PACB
PACB
Q4 25
1.0%
1.9%
Q3 25
1.1%
0.2%
Q2 25
0.5%
1.4%
Q1 25
3.7%
Q4 24
0.2%
4.1%
Q3 24
0.4%
2.0%
Q2 24
0.7%
4.1%
Q1 24
6.8%
10.0%
Cash Conversion
ERII
ERII
PACB
PACB
Q4 25
0.26×
Q3 25
-0.81×
Q2 25
2.02×
Q1 25
Q4 24
0.38×
-12.93×
Q3 24
-0.35×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ERII
ERII

Water Segment$38.6M58%
Other$11.0M16%
Original Equipment Manufacturer$10.6M16%
Aftermarket$6.6M10%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons